Segal Lloyd Mitchell — SEC Form 4 filings

SEC reporting owner CIK 1477123. 6 Form 4 filings on record with FilingPulse; latest filed 2026-01-12.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-04 to 2026-01-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Repare Therapeutics Inc. (RPTX)PRESIDENT AND CEO, Director56 legs · 34,270 sh · $85,1794
Aktis Oncology, Inc. (AKTS)Director13

Form 4 filings — Segal Lloyd Mitchell

FiledFormIssuerReported transactionsSource
2026-01-124Aktis Oncology, Inc. (AKTS)Conversion (C): 19,631 · Conversion (C): 50,000 (derivative) @ $0 · Conversion (C): 24,687 (derivative) @ $0EDGAR
2025-03-144Repare Therapeutics Inc. (RPTX)Sale (S): 21,179 @ $1.14EDGAR
2025-03-064Repare Therapeutics Inc. (RPTX)Grant/award (A): 40,000 @ $0 · Grant/award (A): 237,000 (derivative) @ $0EDGAR
2024-04-014Repare Therapeutics Inc. (RPTX)Sale (S): 2,650 @ $4.62 · Sale (S): 2,491 @ $4.63EDGAR
2024-03-274Repare Therapeutics Inc. (RPTX)Sale (S): 2,650 @ $4.79 · Sale (S): 2,650 @ $4.64 · Sale (S): 2,650 @ $4.63EDGAR
2024-03-044Repare Therapeutics Inc. (RPTX)Grant/award (A): 40,000 @ $0 · Grant/award (A): 237,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1477123 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →